Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Presentations

Corporate Presentation - August 2019

Download the Presentation

LPCN 1144 Presentation

Download the Presentation